Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CB

WKN: A2PGFW | ISIN: CNE100003F01 | Ticker: CJH
Stuttgart
18.11.26 | 21:55
2,560 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
CANSINO BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
CANSINO BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,5602,68018.11.
2,5602,66018.11.

Aktuelle News zur CANSINO BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCANSINOBIO Td5cp Approved for Clinical Trials in China Among Children Aged 4-51
MoCANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - TD5CP OBTAINS CLINICAL TRIAL APPROVAL IN CHINA FOR PEOPLE AGED 4 TO 5 YEARS OLD4
28.10.CANSINOBIO 9M Net Profit Up 12.8% YoY to RMB16.29M5
27.10.CanSino Biologics Inc: CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth680HONG KONG, Oct 27, 2026 - (ACN Newswire) - On October 27, 2026, CanSino Biologics Inc. (HKEX: 06185; SSE: 688185) released its third-quarter financial report for 2026. For the nine months ended September...
► Artikel lesen
27.10.CANSINOBIO (06185): THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 20263
14.10.CANSINOBIO (06185): NOTICE OF BOARD MEETING7
CANSINO BIOLOGICS Aktie jetzt für 0€ handeln
24.09.Connecting Innovation and Global Markets: Jeanne Wang on CanSinoBIO's Next Stage of Growth16
17.09.CANSINOBIO (06185): 2026 INTERIM REPORT9
16.09.CANSINOBIO (06185): ANNOUNCEMENT ON THE GRANT OF RESERVED RESTRICTED SHARES UNDER THE 2025 A SHARE INCENTIVE SCHEME10
27.08.CanSino Biologics Inc: Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities1.273HONG KONG, Aug 27, 2026 - (ACN Newswire) - CanSino Biologics Inc. ('CanSinoBIO,' 06185.HK/688185.SH) released its financial results for the first half of 2026. The Company reported revenue of approximately...
► Artikel lesen
27.08.CANSINOBIO (06185): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20268
26.08.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - UPDATE ON MRNA TECHNOLOGY PLATFORM DEVELOPMENT14
20.08.CANSINOBIO (06185): INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO TETANUS VACCINE13
17.08.Zulassungsantrag für Booster-Impfstoff treibt Aktie von CanSino Biologics an13
17.08.CanSino Biologics Inc: CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline931HONG KONG, Aug 16, 2026 - (ACN Newswire) - On August 16, 2026, CanSino Biologics Inc. ("CanSinoBIO" HKEX: 06185/SHSE: 688185) announced that the New Drug Application (NDA) for its Tetanus, Reduced Diphtheria...
► Artikel lesen
14.08.CANSINOBIO (06185): NOTICE OF BOARD MEETING2
29.06.CanSino Biologics Inc: CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America802HONG KONG, June 29, 2026 - (ACN Newswire) - On June 25, CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197)...
► Artikel lesen
25.06.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - MCV4 OBTAINS DRUG REGISTRATION CERTIFICATE IN ARGENTINA-
10.06.CANSINOBIO (06185): ARTICLES OF ASSOCIATION1
10.06.CANSINOBIO (06185): POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION-
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1